Compare CPBI & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CPBI | HYFT |
|---|---|---|
| Founded | 2023 | 1983 |
| Country | United States | United States |
| Employees | N/A | 102 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.5M | 71.9M |
| IPO Year | 2023 | N/A |
| Metric | CPBI | HYFT |
|---|---|---|
| Price | $18.38 | $1.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 4.9K | ★ 448.7K |
| Earning Date | 06-12-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.80 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $29.18 |
| P/E Ratio | $22.98 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.52 | $0.99 |
| 52 Week High | $18.75 | $3.00 |
| Indicator | CPBI | HYFT |
|---|---|---|
| Relative Strength Index (RSI) | 63.80 | 69.74 |
| Support Level | $16.88 | $1.56 |
| Resistance Level | N/A | $1.93 |
| Average True Range (ATR) | 0.17 | 0.16 |
| MACD | 0.09 | 0.05 |
| Stochastic Oscillator | 74.29 | 72.15 |
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists mainly of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in primary market area, as well as commercial real estate loans.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.